Valuation Astal Laboratories Limited

Stocks

Market Closed - Bombay S.E. 06:02:31 2026-10-01 am EDT			5-day change	1st Jan Change
69.54 ^INR	-1.93%		-2.90%	-19.93%

Aug. 14	Astal Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
May. 30	Astal Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026
Market Cap ¹	34.77	64.34	118.1	401.9	747.2	2,759
Change	-	85.03%	83.54%	240.29%	85.93%	269.28%
Enterprise Value (EV) ¹	34.46	64.16	117.2	344.2	862.6	3,251
Change	-	86.18%	82.75%	193.57%	150.59%	276.91%
P/E	577x	-376x	722x	26.3x	9.45x	8.37x
PBR	0.67x	1.25x	2.27x	1.72x	2.08x	0.83x
PEG	-	1x	-4x	0x	0x	-2.89x
Capitalization / Revenue	17.2x	30.5x	3.27x	1.7x	1.17x	1.11x
EV / Revenue	17.1x	30.4x	3.25x	1.45x	1.36x	1.31x
EV / EBITDA	-	-	-	-	-	-
EV / EBIT	-	-	-	-	-	-
EV / FCF	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	0.0152	-0.0431	0.041	1.554	8.043	7.81
Distribution rate	-	-	-	-	-	-
Net sales ¹	2.019	2.108	36.07	236.6	636.6	2,486
EBITDA	-	-	-	-	-	-
EBIT	-	-	-	-	-	-
Net income ¹	0.0602	-0.1711	0.164	7.847	89.25	147.1
Net Debt ¹	-0.3129	-0.1828	-0.844	-57.64	115.4	491.9
Reference price ²	8.75	16.19	29.60	40.88	76.01	65.36
Nbr of stocks (in thousands)	3,974	3,974	3,990	9,830	9,830	42,216
Announcement Date	9/1/21	9/8/22	8/25/23	7/12/24	8/18/25	9/7/26

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ASTAL LABORATORIES LIMITED	-	-	-	-	31.68M
ELI LILLY AND COMPANY	32.45x	11.78x	23.93x	0.61%	1,019B
JOHNSON & JOHNSON	28.48x	6.32x	17.7x	2.09%	617B
ABBVIE INC.	33.26x	7.78x	16.08x	2.64%	464B
MERCK & CO., INC.	104.98x	5.87x	24.89x	2.36%	356B
ROCHE HOLDING AG	18.81x	4.58x	11.36x	2.9%	333B
NOVARTIS AG	19.83x	5.17x	12.78x	3.09%	267B
ASTRAZENECA PLC	20.02x	4.17x	11.86x	2.13%	244B
AMGEN INC.	25.46x	6.66x	11.86x	2.5%	218B
GILEAD SCIENCES, INC.	-43.78x	6.39x	24.97x	2.27%	179B
Average	26.61x	6.52x	17.27x	2.29%	369.72B
Weighted average by Cap.	31.80x	7.61x	18.61x	1.96%